Literature DB >> 6771081

Poliomyelitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease.

M M Esiri.   

Abstract

The immunoperoxidase method has been used to demonstrate the presence of immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of poliomyelitis. These cells were found in considerable numbers in the areas of damage during the acute phase, and persisted at the same sites, though in smaller numbers, during the convalescent phase for at least 8 months. Most of the positively stained cells were plasma cells. IgA was the commonest heavy chain type demonstrated, with lesser amounts also of IgG and, during the acute phase, IgM. In the acute phase more lambda than kappa light chain was demonstrated but in the convalescent phase this ratio was reversed. More light chain than heavy chain was demonstrable during the acute phase. The significance of these results is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771081      PMCID: PMC1536960     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  6 in total

1.  Studies of local antibody formation in the nervous system of paralyzed, poliomyelitis convalescent monkeys.

Authors:  A B SABIN; A J STEIGMAN
Journal:  J Immunol       Date:  1949-10       Impact factor: 5.422

Review 2.  Characteristics of the immune response within the CNS in neurological disorders.

Authors:  H Link
Journal:  Acta Neurol Scand Suppl       Date:  1978

3.  Poliovirus neutralizing antibody in cerebrospinal fluid.

Authors:  M M Lipton; A J Steigman; F C Dizon
Journal:  J Infect Dis       Date:  1965-10       Impact factor: 5.226

4.  Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology.

Authors:  A Fryden; H Link; E Norrby
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Immunoglobulin-containing cells in multiple-sclerosis plaques.

Authors:  M M Esiri
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

  6 in total
  8 in total

1.  The immune system and the nervous system.

Authors:  J A Aarli
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

2.  Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis.

Authors:  T R Moench; D E Griffin
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

3.  Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

4.  Ependymitis, leukoencephalitis, hydrocephalus, and thrombotic vasculitis following chronic infection by mouse hepatitis virus 3 (MHV 3).

Authors:  M Tardieu; A Goffinet; G Harmant-van Rijckevorsel; G Lyon
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies.

Authors:  B Vandvik; F Vartdal; E Norrby
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

6.  Intrathecal antibody synthesis to virus antigens in multiple sclerosis.

Authors:  A Salmi; M Reunanen; J Ilonen; M Panelius
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

7.  Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection.

Authors:  D Moskophidis; J Löhler; F Lehmann-Grube
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

8.  Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.

Authors:  Jingya Xia; Ronald L Veselenak; Summer R Gorder; Nigel Bourne; Gregg N Milligan
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.